BioHiTech Global, Inc. Income Statement 2020-2011 | BHTG

Brief overview of profit and loss at BioHiTech Global, Inc.

This overview is based on financial performance over the past five years. The revenue attributed to BioHiTech Global, Inc. moved from 1.5 million dollars to 5.9 million dollars between the two endpoints. The cumulative result was +288.3%, corresponding to roughly 31.2% per year. The company expanded its revenue base at a high speed.

At the gross-profit level, the result moved from 188 thousand dollars to 5.9 million dollars, a change of +3024.1%. Gross margin moved from 12.4% to 100%. The margin shift points to a more favorable sales-and-cost structure.

EBITDA changed from −$4.4 million to −$9.4 million (−114.9%). EBITDA underperformed the top-line trend. The EBITDA share of revenue changed from −287.9% to −159.4%. Higher profitability strengthens the quality of operating growth.

Comparing the endpoints shows a move from −$5 million to −$15.7 million. Larger losses indicate rising pressure on the business.

Market value was $34.8 million at the start and $30.3 million at the end. The financial trend was stronger than the market valuation.

Overall conclusion

The financial profile remains mixed, with strengths and risks moving in different directions. The financial profile benefits from an improving EBITDA margin, revenue expansion and a stronger gross margin. Caution is warranted because of limited operating profitability and declining net profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.